Bone Structure and Turnover in Postmenopausal Women With Long-Standing Type 1 Diabetes

Compromised bone structural and mechanical properties are implicated in the increased fracture risk in type 1 diabetes (T1D). We investigated bone structure and turnover by histomorphometry in postmenopausal women with T1D and controls without diabetes using tetracycline double-labeled transiliac bone biopsy. After in vivo tetracycline double labeling, postmenopausal women with T1D of at least 10 years and without diabetes underwent transiliac bone biopsy. An expert blinded to the study group performed histomorphometry. Static and dynamic histomorphometry measurements were performed and compared between the two groups. The analysis included 9 postmenopausal women with T1D (mean age 58.4 +/- 7.1 years with 37.9 +/- 10.9 years of diabetes and HbA1c 7.1% +/- 0.4%) and 7 postmenopausal women without diabetes (mean age 60.9 +/- 3.3 years and HbA1c 5.4% +/- 0.2%). There were no significant differences in serum PTH (38.6 +/- 8.1 versus 51.9 +/- 23.9 pg/mL), CTX (0.4 +/- 0.2 versus 0.51 +/- 0.34 ng/mL), or P1NP (64.5 +/- 26.2 versus 87.3 +/- 45.3 ng/mL). Serum 25-hydroxyvitamin D levels were higher in T1D than in controls (53.1 +/- 20.8 versus 30.9 +/- 8.2 ng/mL, p < 0.05). Bone structure metrics (bone volume, trabecular thickness, trabecular number, and cortical thickness) were similar between the groups. Indices of bone formation (osteoid volume, osteoid surface, and bone formation rate) were 40% lower in T1D and associated with lower activation frequency. However, the differences in bone formation were not statistically significant. Long-standing T1D may affect bone turnover, mainly bone formation, without significantly affecting bone structure. Further research is needed to understand bone turnover and factors affecting bone turnover in people with T1D. (c) 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.